321 related articles for article (PubMed ID: 37760849)
21. Displacing the Burden: A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease.
Sánchez-Ospina D; Mas-Fontao S; Gracia-Iguacel C; Avello A; González de Rivera M; Mujika-Marticorena M; Gonzalez-Parra E
J Clin Med; 2024 Mar; 13(5):. PubMed ID: 38592263
[TBL] [Abstract][Full Text] [Related]
22. Tubular cells produce FGF2 via autophagy after acute kidney injury leading to fibroblast activation and renal fibrosis.
Livingston MJ; Shu S; Fan Y; Li Z; Jiao Q; Yin XM; Venkatachalam MA; Dong Z
Autophagy; 2023 Jan; 19(1):256-277. PubMed ID: 35491858
[TBL] [Abstract][Full Text] [Related]
23. The Role of Gut-Derived, Protein-Bound Uremic Toxins in the Cardiovascular Complications of Acute Kidney Injury.
Caillard P; Bennis Y; Six I; Bodeau S; Kamel S; Choukroun G; Maizel J; Titeca-Beauport D
Toxins (Basel); 2022 May; 14(5):. PubMed ID: 35622583
[TBL] [Abstract][Full Text] [Related]
24. Bioengineered Kidney Tubules Efficiently Clear Uremic Toxins in Experimental Dialysis Conditions.
Faria J; Ahmed S; Stamatialis D; Verhaar MC; Masereeuw R; Gerritsen KGF; Mihăilă SM
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569805
[TBL] [Abstract][Full Text] [Related]
25. Gut-Derived Protein-Bound Uremic Toxins.
Graboski AL; Redinbo MR
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932981
[TBL] [Abstract][Full Text] [Related]
26. Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome.
van Gelder MK; Middel IR; Vernooij RWM; Bots ML; Verhaar MC; Masereeuw R; Grooteman MP; Nubé MJ; van den Dorpel MA; Blankestijn PJ; Rookmaaker MB; Gerritsen KGF
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32272776
[TBL] [Abstract][Full Text] [Related]
27. Disposition and clinical implications of protein-bound uremic toxins.
Jansen J; Jankowski J; Gajjala PR; Wetzels JFM; Masereeuw R
Clin Sci (Lond); 2017 Jul; 131(14):1631-1647. PubMed ID: 28667064
[TBL] [Abstract][Full Text] [Related]
28. N-acetylcysteine delayed cadmium-induced chronic kidney injury by activating the sirtuin 1-P53 signaling pathway.
Dong W; Zhang K; Gong Z; Luo T; Li J; Wang X; Zou H; Song R; Zhu J; Ma Y; Liu G; Liu Z
Chem Biol Interact; 2023 Jan; 369():110299. PubMed ID: 36493885
[TBL] [Abstract][Full Text] [Related]
29. Protein-Bound Uremic Toxins and Immunity.
Rocchetti MT; Cosola C; Ranieri E; Gesualdo L
Methods Mol Biol; 2021; 2325():215-227. PubMed ID: 34053061
[TBL] [Abstract][Full Text] [Related]
30. P
Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
[TBL] [Abstract][Full Text] [Related]
31. The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction.
Cunha RSD; Azevedo CAB; Falconi CA; Ruiz FF; Liabeuf S; Carneiro-Ramos MS; Stinghen AEM
Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324674
[TBL] [Abstract][Full Text] [Related]
32. Ageing, cellular senescence and chronic kidney disease: experimental evidence.
Tan H; Xu J; Liu Y
Curr Opin Nephrol Hypertens; 2022 May; 31(3):235-243. PubMed ID: 35142744
[TBL] [Abstract][Full Text] [Related]
33. Cellular senescence of renal tubular epithelial cells in renal fibrosis.
Zhang JQ; Li YY; Zhang XY; Tian ZH; Liu C; Wang ST; Zhang FR
Front Endocrinol (Lausanne); 2023; 14():1085605. PubMed ID: 36926022
[TBL] [Abstract][Full Text] [Related]
34. Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease.
Faria M; de Pinho MN
Transl Res; 2021 Mar; 229():115-134. PubMed ID: 32891787
[TBL] [Abstract][Full Text] [Related]
35. VNN1 contributes to the acute kidney injury-chronic kidney disease transition by promoting cellular senescence via affecting RB1 expression.
Chen J; Lu H; Wang X; Yang J; Luo J; Wang L; Yi X; He Y; Chen K
FASEB J; 2022 Sep; 36(9):e22472. PubMed ID: 35959877
[TBL] [Abstract][Full Text] [Related]
36. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
37. Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease.
Chinnappa S; Tu YK; Yeh YC; Glorieux G; Vanholder R; Mooney A
Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30563136
[TBL] [Abstract][Full Text] [Related]
38. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
[TBL] [Abstract][Full Text] [Related]
39. Role of Uremic Toxins, Oxidative Stress, and Renal Fibrosis in Chronic Kidney Disease.
Frąk W; Dąbek B; Balcerczyk-Lis M; Motor J; Radzioch E; Młynarska E; Rysz J; Franczyk B
Antioxidants (Basel); 2024 Jun; 13(6):. PubMed ID: 38929126
[TBL] [Abstract][Full Text] [Related]
40. Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease.
Steenbeke M; Valkenburg S; Gryp T; Van Biesen W; Delanghe JR; Speeckaert MM; Glorieux G
Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
